<SEC-DOCUMENT>0001140361-25-026611-index.html : 20250721
<SEC-HEADER>0001140361-25-026611.hdr.sgml : 20250721
<ACCEPTANCE-DATETIME>20250721160539
ACCESSION NUMBER:		0001140361-25-026611
CONFORMED SUBMISSION TYPE:	DEF 14A
PUBLIC DOCUMENT COUNT:		26
CONFORMED PERIOD OF REPORT:	20250807
FILED AS OF DATE:		20250721
DATE AS OF CHANGE:		20250721

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			PLUS THERAPEUTICS, INC.
		CENTRAL INDEX KEY:			0001095981
		STANDARD INDUSTRIAL CLASSIFICATION:	SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
		ORGANIZATION NAME:           	08 Industrial Applications and Services
		EIN:				330827593
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		DEF 14A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-34375
		FILM NUMBER:		251137322

	BUSINESS ADDRESS:	
		STREET 1:		4200 MARATHON BLVD.
		STREET 2:		SUITE 200
		CITY:			AUSTIN
		STATE:			TX
		ZIP:			78756
		BUSINESS PHONE:		737.255.7194

	MAIL ADDRESS:	
		STREET 1:		4200 MARATHON BLVD.
		STREET 2:		SUITE 200
		CITY:			AUSTIN
		STATE:			TX
		ZIP:			78756

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	CYTORI THERAPEUTICS, INC.
		DATE OF NAME CHANGE:	20050712

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	MACROPORE INC
		DATE OF NAME CHANGE:	20010320
</SEC-HEADER>
<DOCUMENT>
<TYPE>DEF 14A
<SEQUENCE>1
<FILENAME>ny20044912x2_def14a.htm
<DESCRIPTION>DEF 14A
<TEXT>
Document 1 - file: ny20044912x2_def14a.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>2
<FILENAME>pstv-20250807_lab.xml
<DESCRIPTION>INLINE XBRL TAXONOMY EXTENSION - LABEL LINKBASE
<TEXT>
Document 2 - file: pstv-20250807_lab.xml

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>3
<FILENAME>pstv-20250807.xsd
<DESCRIPTION>INLINE XBRL TAXONOMY EXTENSION - SCHEMA
<TEXT>
Document 3 - file: pstv-20250807.xsd

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>logo_plustherapeutics.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
Document 4 - file: logo_plustherapeutics.jpg

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>logo_plustherapeuticsx1.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
Document 5 - file: logo_plustherapeuticsx1.jpg

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>sig_marchedrick.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
Document 6 - file: sig_marchedrick.jpg

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>7
<FILENAME>sig_marchedrickx1.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
Document 7 - file: sig_marchedrickx1.jpg

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>8
<FILENAME>ny20044912x2_chair.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
Document 8 - file: ny20044912x2_chair.jpg

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>9
<FILENAME>ny20044912x2_expert.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
Document 9 - file: ny20044912x2_expert.jpg

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>10
<FILENAME>ny20044912x2_member.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
Document 10 - file: ny20044912x2_member.jpg

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>11
<FILENAME>ny20044912x2_pc01.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
Document 11 - file: ny20044912x2_pc01.jpg

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>12
<FILENAME>ny20044912x2_pc02.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
Document 12 - file: ny20044912x2_pc02.jpg

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>13
<FILENAME>ny20044912x2_pvpchart01.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
Document 13 - file: ny20044912x2_pvpchart01.jpg

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>14
<FILENAME>ny20044912x2_pvpchart02.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
Document 14 - file: ny20044912x2_pvpchart02.jpg

</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
Document 20 - file: Show.js

</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
Document 21 - file: report.css

</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>26
<FILENAME>0001140361-25-026611-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
Document 26 - file: 0001140361-25-026611-xbrl.zip

</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>ny20044912x2_def14a_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
Document 29 - file: ny20044912x2_def14a_htm.html

Document 29 - RAW XML: ny20044912x2_def14a_htm.xml

</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
Document 30 - file: R1.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
Document 31 - file: R2.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
Document 32 - file: R3.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
Document 33 - file: R4.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
Document 34 - file: FilingSummary.html

Document 34 - RAW XML: FilingSummary.xml

</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>36
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
Document 36 - file: MetaLinks.json

</DOCUMENT>
</SEC-DOCUMENT>